Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab. [electronic resource]
Producer: 20190827Description: 1536012119829986 p. digitalISSN:- 1536-0121
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- B7-H1 Antigen -- metabolism
- Breast Neoplasms -- diagnostic imaging
- Deferoxamine -- chemistry
- Dose-Response Relationship, Drug
- Down-Regulation
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Immunoconjugates
- Mice
- Positron-Emission Tomography
- Radioisotopes -- chemistry
- Tissue Distribution
- Treatment Outcome
- Xenograft Model Antitumor Assays
- Zirconium -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.